Eman Abdel Rahman Ismail
Overview
Explore the profile of Eman Abdel Rahman Ismail including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
388
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elbarbary N, Rahman Ismail E
Diabetes Res Clin Pract
. 2025 Feb;
221:112042.
PMID: 39965719
Background: Time in tight range (TITR) is a novel glycemic metric assessing normoglycemia in individuals with diabetes. Aim: To assess the attainability of the TITR (70-140 mg/dL) target in youth...
2.
ElKabbany Z, Rahman Ismail E, Hamed E, Elbarbary N
Diabetes Obes Metab
. 2024 Sep;
26(12):5857-5869.
PMID: 39318059
Aim: Many patients with type 1 diabetes mellitus (T1DM) met the histological criteria for non-alcoholic steatohepatitis (NASH), which leads to cardiovascular disease morbidity and mortality. Matrix metalloproteinase-14 (MMP-14) is involved...
3.
Adly A, Rahman Ismail E, A Ibrahim F, Atef M, El Sayed K, Aly N
J Inherit Metab Dis
. 2024 Aug;
48(1):e12792.
PMID: 39183538
Enzymatic deficiency in Gaucher disease (GD) may induce oxidative stress. Vitamin E is the nature's most effective lipid-soluble antioxidant. This prospective clinical trial assessed the oxidant-antioxidant status in Egyptian patients...
4.
Elbarbary N, Rahman Ismail E
Diabetol Metab Syndr
. 2023 Dec;
15(1):257.
PMID: 38057844
Background: Ramadan Iftar meal typically causes glucose excursions. Dipeptidyl peptidase-4 inhibitors increase glucagon-like peptide-1 and thus, decrease blood glucose levels with low risk of hypoglycemia. Aim: To investigate the efficacy...
5.
Elbarbary N, Rahman Ismail E, Mohamed S
Clin Nutr
. 2023 Oct;
42(12):2372-2380.
PMID: 37862823
Background: Numerous studies have evaluated the beneficial effects of omega-3 fatty acids on inflammatory, autoimmune and renal diseases. However, data about the effects of omega-3 fatty acids on diabetic kidney...
6.
Elbarbary N, Rahman Ismail E
Diabetol Metab Syndr
. 2023 Oct;
15(1):205.
PMID: 37845757
Background: Advanced hybrid closed loop (AHCL) system provides both automated basal rate and correction boluses to keep glycemic values in a target range. Objectives: To evaluate the real-world performance of...
7.
Abo El-Asrar M, Rahman Ismail E, Elnhrawy A, Thabet R
J Diabetes Complications
. 2023 Feb;
37(3):108414.
PMID: 36758511
Background: Diabetic nephropathy is a major cause of morbidity and mortality in type 1 diabetes mellitus (T1DM). Fatty acid binding proteins (FABP1 and FABP2) play a role in the development...
8.
Tantawy A, Elsherif N, Ebeid F, El-Gamal R, Rahman Ismail E, Kenny M, et al.
J Thromb Thrombolysis
. 2022 Dec;
55(2):243-251.
PMID: 36479670
Background: Platelet glycoprotein VI (GPVI) receptor is essential for platelet adhesion and aggregation. Eltrombopag is as an effective treatment for chronic immune thrombocytopenia (ITP); yet, its effect on platelet function...
9.
Tantawy A, Tadros M, Adly A, Rahman Ismail E, A Ibrahim F, Salah Eldin N, et al.
Cytokine
. 2022 Oct;
161:156048.
PMID: 36279697
Background: Endothelin-1 (ET-1), a potent endogenous vasoconstrictor, stimulates production of reactive oxygen species. Endothelial monocyte-activating polypeptide-II (EMAP-II) is a multifunctional polypeptide. Aim: To assess ET-1 gene polymorphism (G8002A) in pediatric...
10.
Elbarbary N, Rahman Ismail E
Diabetes Res Clin Pract
. 2022 Aug;
191:110045.
PMID: 35987309
Background: MiniMed 780G is the most advanced insulin pump system approved for the treatment of type 1 diabetes mellitus (T1DM). Hypoglycemic events are a serious complication associated with T1DM management...